SPP1 and diabetes mellitus: This is considered a potential biomarker for the early identification and intervention of CAD in patients with diabetes.21 Osteopontin (OPN) is a multifunctional phosphorylated glycoprotein, that functions as an inflammatory cytokine and pro-atherosclerotic factor.